plus whatever RVNC spends developing any indications it wouldn't otherwise have developed.
I did not factor that in, however I guess I was focusing more on the defensive benefits for Allergan. As you stated they could have been too arrogant or it could have simply been an oversight on their part.
Market Data 
Markets 
